VANCOUVER, British Columbia and LAS VEGAS, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc...
Hydreight reported record Topline¹ Revenue of $10.46M in the first 6 months of 2024.Q2, 2024 GAAP revenue was...
LAS VEGAS and VANCOUVER, British Columbia, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc...
“We had another outstanding quarter with record revenue and positive Adjusted EBITDA Our focus in 2024 is to...
VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory...
VANCOUVER, British Columbia and LAS VEGAS, July 11, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc...
VANCOUVER, British Columbia and LAS VEGAS, June 26, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies...
VANCOUVER, British Columbia, June 12, 2024 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory...
VANCOUVER, British Columbia and LAS VEGAS, June 12, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies...
VS Digital Health is launching this healthcare platform in partnership with Hydreight Technologies and DSV...
Hydreight Technologies is launching this healthcare platform in partnership with VS Digital Health and DSV...
Topline Revenue for the three-months ended March 31, 2024, was $5,052,069Cash & liquid securities approx...
VANCOUVER, British Columbia and LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies...
VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory...
Tirzepatide, a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA), is an antidiabetic medication used for the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.